Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review
Phosphodiesterase type 5 inhibitors such as sildenafil citrate and tadalafil are well known for the treatment of erectile dysfunction. However, their use in the presence of pulmonary hypertension can cause ophthalmologic side effects, including non-arteritic optic ischemic neuropathy, chorioretinopa...
Main Authors: | Francisco Barroso, João Crispim Ribeiro, Eduardo P. Miranda |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2021-05-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | https://doi.org/10.18502/jovr.v16i2.9088 |
Similar Items
-
The impact of phosphodiesterase-5 inhibitor (sildenafil citrate) on some hippocampal neurotransmitters, oxidative stress status, minerals, and anxiety-like behavior in rats
by: Mona Hafez Hafez, et al.
Published: (2020-06-01) -
Psychosis beas a rare side effect of sildenafil: a case report
by: Mohammadreza Shalbafan, et al.
Published: (2022-03-01) -
No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma
by: Jenny Z. Wang, et al.
Published: (2019-09-01) -
The Survey of Angiogenesis and Myometrial Thickness of Preimplantation Mouse Uterine in Natural Cycle in those Received Human Menopausal Gonadotropin-Human Chorionic Gonadotropin (HMG–HCG) and Sildenafil Citrate
by: Gholamreza Dashti, et al.
Published: (2017-11-01) -
Sildenafil citrate therapy for secondary pulmonary arterial hypertension due to chronic obstructive lung disease
by: Khaled Alkhayat, et al.
Published: (2016-10-01)